SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED
Company number 10778679
- Company Overview for SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED (10778679)
- Filing history for SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED (10778679)
- People for SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED (10778679)
- Charges for SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED (10778679)
- More for SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED (10778679)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
09 May 2024 | CS01 | Confirmation statement made on 9 May 2024 with updates | |
22 Mar 2024 | AA | Micro company accounts made up to 31 March 2023 | |
26 May 2023 | AD01 | Registered office address changed from 3rd Floor, 141-145 Curtain Road London Greater London EC2A 3BX England to Level 4 Ldn:W 3 Noble Street London EC2V 7EE on 26 May 2023 | |
11 May 2023 | CS01 | Confirmation statement made on 11 May 2023 with updates | |
31 Mar 2023 | AA | Unaudited abridged accounts made up to 31 March 2022 | |
27 May 2022 | CS01 | Confirmation statement made on 17 May 2022 with updates | |
30 Dec 2021 | AA | Unaudited abridged accounts made up to 31 March 2021 | |
18 Jun 2021 | AD01 | Registered office address changed from Delta Place 27 Bath Road Cheltenham GL53 7th England to 3rd Floor, 141-145 Curtain Road London Greater London EC2A 3BX on 18 June 2021 | |
25 May 2021 | TM01 | Termination of appointment of Duncan Saxon Tate as a director on 29 April 2021 | |
25 May 2021 | AA | Unaudited abridged accounts made up to 31 March 2020 | |
24 May 2021 | CS01 | Confirmation statement made on 17 May 2021 with updates | |
29 May 2020 | CS01 | Confirmation statement made on 17 May 2020 with updates | |
23 Dec 2019 | AA | Unaudited abridged accounts made up to 31 March 2019 | |
25 Sep 2019 | MR01 | Registration of charge 107786790001, created on 16 September 2019 | |
04 Sep 2019 | AA01 | Previous accounting period shortened from 31 May 2019 to 31 March 2019 | |
17 May 2019 | CS01 | Confirmation statement made on 17 May 2019 with updates | |
30 Apr 2019 | CH01 | Director's details changed for Mr Andrew Jonathan Charles Newman on 1 April 2019 | |
23 Apr 2019 | SH01 |
Statement of capital following an allotment of shares on 5 April 2019
|
|
19 Feb 2019 | AA | Total exemption full accounts made up to 31 May 2018 | |
23 Jan 2019 | CH01 | Director's details changed for Mr Duncan Saxon Tate on 18 January 2019 | |
11 Sep 2018 | RESOLUTIONS |
Resolutions
|
|
07 Jun 2018 | TM01 | Termination of appointment of Alan Adi Yazdabadi as a director on 23 May 2018 | |
07 Jun 2018 | AP01 | Appointment of Mr Andrew Jonathan Charles Newman as a director on 3 April 2018 | |
07 Jun 2018 | AP01 | Appointment of Mr Duncan Saxon Tate as a director on 3 April 2018 | |
06 Jun 2018 | PSC08 | Notification of a person with significant control statement |